Holdings of VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS · 88 declared positions · as of Apr 30, 2026
Original filing · Net assets 36.9B $ · Ten largest lines: 41.4 % of the equity sleeve
Sector breakdown
- Health care 75.4 %
- Industrials 0.8 %
- Materials 0.6 %
- Unattributed 23.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 75.4 %
- GBP 8.4 %
- JPY 5.5 %
- CHF 4.2 %
- EUR 4.0 %
- DKK 1.5 %
- HKD 1.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 74.2 %
- GB 8.4 %
- JP 5.5 %
- CH 4.2 %
- BE 4.0 %
- DK 1.5 %
- HK 1.1 %
- IE 0.5 %
- CA 0.4 %
- NL 0.3 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 65 | 26.9B $ | 74.17 % |
| GB | 2 | 3B $ | 8.36 % |
| JP | 6 | 2B $ | 5.52 % |
| CH | 3 | 1.5B $ | 4.20 % |
| BE | 2 | 1.5B $ | 4.01 % |
| DK | 2 | 532.1M $ | 1.47 % |
| HK | 5 | 396.8M $ | 1.09 % |
| IE | 1 | 182M $ | 0.50 % |
| CA | 1 | 150M $ | 0.41 % |
| NL | 1 | 97.8M $ | 0.27 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co | 3,582,833 | 3.3B $ | 9.08 % |
| Merck & Co Inc | 18,279,775 | 2B $ | 5.41 % |
| AstraZeneca PLC | 9,897,175 | 1.9B $ | 5.09 % |
| UnitedHealth Group Inc | 3,895,307 | 1.4B $ | 3.92 % |
| Johnson & Johnson | 5,527,324 | 1.3B $ | 3.45 % |
| Edwards Lifesciences Corp | 14,158,652 | 1.2B $ | 3.21 % |
| GSK PLC | 44,002,585 | 1.2B $ | 3.13 % |
| Intuitive Surgical Inc | 2,186,666 | 1B $ | 2.71 % |
| Boston Scientific Corp | 15,070,438 | 868.2M $ | 2.36 % |
| Danaher Corp | 4,836,473 | 865.5M $ | 2.35 % |
| CVS Health Corp | 9,756,578 | 812.6M $ | 2.20 % |
| Argenx SE | 1,036,146 | 812.6M $ | 2.20 % |
| Abbott Laboratories | 8,842,005 | 802.8M $ | 2.18 % |
| Vertex Pharmaceuticals Inc | 1,801,919 | 770.1M $ | 2.09 % |
| Cencora Inc | 2,484,451 | 765.2M $ | 2.08 % |
| Elevance Health Inc | 1,858,361 | 699.5M $ | 1.90 % |
| Regeneron Pharmaceuticals, Inc. | 931,886 | 658.9M $ | 1.79 % |
| UCB SA | 2,355,442 | 641.4M $ | 1.74 % |
| Novartis AG | 4,043,167 | 597.5M $ | 1.62 % |
| HCA Healthcare Inc | 1,203,410 | 522.8M $ | 1.42 % |
| Alnylam Pharmaceuticals Inc | 1,670,679 | 517.1M $ | 1.40 % |
| AbbVie Inc | 2,356,112 | 497.9M $ | 1.35 % |
| Biogen Inc | 2,526,097 | 478.1M $ | 1.30 % |
| United Therapeutics Corp | 822,896 | 470.2M $ | 1.28 % |
| Galderma Group AG | 2,228,631 | 467.6M $ | 1.27 % |
| Chugai Pharmaceutical Co Ltd | 8,606,142 | 459M $ | 1.25 % |
| Roche Holding AG | 1,122,465 | 457.4M $ | 1.24 % |
| Otsuka Holdings Co Ltd | 6,207,200 | 452.4M $ | 1.23 % |
| Cardinal Health, Inc. | 2,317,298 | 447M $ | 1.21 % |
| Agilent Technologies Inc | 3,824,222 | 441.9M $ | 1.20 % |
| Shionogi & Co Ltd | 20,439,649 | 412.9M $ | 1.12 % |
| Dexcom Inc | 6,365,180 | 379M $ | 1.03 % |
| Daiichi Sankyo Co Ltd | 22,675,166 | 368.3M $ | 1.00 % |
| Thermo Fisher Scientific Inc | 745,695 | 357.2M $ | 0.97 % |
| Genmab A/S | 1,345,944 | 356.4M $ | 0.97 % |
| Medtronic PLC | 4,228,128 | 342.4M $ | 0.93 % |
| Stryker Corp | 970,510 | 305.8M $ | 0.83 % |
| Ionis Pharmaceuticals Inc | 3,803,181 | 284.3M $ | 0.77 % |
| Revolution Medicines Inc | 1,838,404 | 265M $ | 0.72 % |
| Ascendis Pharma A/S | 1,049,942 | 240.8M $ | 0.65 % |
| STERIS PLC | 1,092,821 | 237M $ | 0.64 % |
| Incyte Corp | 2,365,620 | 225.4M $ | 0.61 % |
| QIAGEN NV | 6,514,443 | 225.3M $ | 0.61 % |
| Cytokinetics Inc | 3,482,614 | 222.8M $ | 0.60 % |
| Bristol-Myers Squibb Co | 3,661,639 | 221.9M $ | 0.60 % |
| Eisai Co Ltd | 7,339,417 | 219.7M $ | 0.60 % |
| Madrigal Pharmaceuticals Inc | 408,918 | 211.6M $ | 0.57 % |
| ICON PLC | 1,538,110 | 182M $ | 0.49 % |
| Novo Nordisk A/S | 4,131,421 | 175.7M $ | 0.48 % |
| CG oncology Inc | 2,589,248 | 172.8M $ | 0.47 % |
| HeartFlow Inc | 5,663,321 | 168.5M $ | 0.46 % |
| Avantor Inc | 20,480,758 | 165.9M $ | 0.45 % |
| Scholar Rock Holding Corp | 3,466,533 | 161.6M $ | 0.44 % |
| Encompass Health Corp | 1,600,016 | 160M $ | 0.43 % |
| Vaxcyte Inc | 2,667,349 | 152.7M $ | 0.41 % |
| Xenon Pharmaceuticals Inc | 2,676,154 | 150M $ | 0.41 % |
| Kymera Therapeutics Inc | 1,796,469 | 145.6M $ | 0.40 % |
| Alignment Healthcare Inc | 6,287,140 | 141.7M $ | 0.38 % |
| Celldex Therapeutics Inc | 4,279,485 | 140.7M $ | 0.38 % |
| Protagonist Therapeutics Inc | 1,380,445 | 136.6M $ | 0.37 % |
| Crinetics Pharmaceuticals Inc | 3,494,255 | 135.5M $ | 0.37 % |
| PTC Therapeutics Inc | 2,038,232 | 132.6M $ | 0.36 % |
| Acadia Healthcare Co Inc | 5,021,479 | 130M $ | 0.35 % |
| Option Care Health Inc | 6,323,420 | 128.6M $ | 0.35 % |
| Apogee Therapeutics Inc | 1,490,737 | 123.6M $ | 0.34 % |
| Structure Therapeutics Inc | 2,909,218 | 120.6M $ | 0.33 % |
| Immunocore Holdings PLC | 4,246,274 | 118.5M $ | 0.32 % |
| Inspire Medical Systems Inc | 2,093,826 | 117.5M $ | 0.32 % |
| Dianthus Therapeutics Inc | 1,244,555 | 109.3M $ | 0.30 % |
| GenFleet Therapeutics Shanghai Inc | 18,491,938 | 102.9M $ | 0.28 % |
| Bio-Techne Corp | 1,825,455 | 101M $ | 0.27 % |
| Duality Biotherapeutics Inc | 2,771,377 | 98.9M $ | 0.27 % |
| Newamsterdam Pharma Co NV | 3,425,823 | 97.8M $ | 0.27 % |
| Natera Inc | 470,036 | 96.9M $ | 0.26 % |
| Moderna Inc | 1,995,366 | 91.7M $ | 0.25 % |
| M3, Inc. | 9,451,653 | 91M $ | 0.25 % |
| Arcus Biosciences Inc | 3,445,827 | 87.9M $ | 0.24 % |
| Nuvalent Inc | 873,258 | 87.6M $ | 0.24 % |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 9,939,973 | 82.9M $ | 0.22 % |
| Zai Lab Ltd | 36,431,700 | 78.2M $ | 0.21 % |
| Centene Corp | 1,363,754 | 73.2M $ | 0.20 % |
| Bridgebio Pharma Inc | 982,977 | 69.9M $ | 0.19 % |
| Immunome Inc | 2,776,580 | 63.7M $ | 0.17 % |
| Stoke Therapeutics Inc | 1,652,492 | 54.1M $ | 0.15 % |
| Kailera Therapeutics Inc | 2,127,264 | 53.2M $ | 0.14 % |
| Mineralys Therapeutics Inc | 1,858,489 | 49.5M $ | 0.13 % |
| Aktis Oncology Inc | 2,023,644 | 37.9M $ | 0.10 % |
| Shandong Weigao Group Medical Polymer Co Ltd | 77,092,000 | 34M $ | 0.09 % |